Achieve Life Sciences (ACHV) Cash & Equivalents (2010 - 2026)
Achieve Life Sciences (ACHV) recorded Cash & Equivalents of $47.96 million in Q2 2026, down 7.5% from $51.87 million a year earlier but up 70.8% from the prior quarter.
Achieve Life Sciences (ACHV) Cash & Equivalents (2010 - 2026) Analysis & Trends
At the end of FY2025, Achieve Life Sciences reported Cash & Equivalents of $20.93 million, up 64.1% from FY2024.
- Annual Cash & Equivalents has a five-year compound annual growth rate of -10.2% (FY2020 to FY2025).
- Across earlier years, Cash & Equivalents came in at $12.75 million in FY2024 (-18.0%), $15.55 million in FY2023 (-37.2%), $24.77 million in FY2022 (-42.4%) and $43.02 million in FY2021 (+20.0%).
- Quarterly Cash & Equivalents has ranged from $9.54 million in Q3 2024 to $66.4 million in Q1 2024 over the past five years.
- On a year-over-year basis, Cash & Equivalents rose in four of the last eight quarters, with growth averaging 63.5%.
- Peak year-over-year performance for Cash & Equivalents in the last five years was growth of 302.1% in Q1 2024, against a decline of 80.4% in Q1 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $28.08 million (Q1 2026), $20.93 million (Q4 2025) and $31.93 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Achieve Life Sciences | 328.27 Mn | 328.27 Mn | - | 47.96 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 47.96 Mn |
| Mar 31, 2026 | 28.08 Mn |
| Dec 31, 2025 | 20.93 Mn |
| Sep 30, 2025 | 31.93 Mn |
| Jun 30, 2025 | 51.87 Mn |
| Mar 31, 2025 | 13.02 Mn |
| Dec 31, 2024 | 12.75 Mn |
| Sep 30, 2024 | 9.54 Mn |
| Jun 30, 2024 | 14.76 Mn |
| Mar 31, 2024 | 66.40 Mn |
| Dec 31, 2023 | 15.55 Mn |
| Sep 30, 2023 | 19.92 Mn |
| Jun 30, 2023 | 25.10 Mn |
| Mar 31, 2023 | 16.51 Mn |
| Dec 31, 2022 | 24.77 Mn |
| Sep 30, 2022 | 18.20 Mn |
| Jun 30, 2022 | 29.40 Mn |
| Mar 31, 2022 | 36.34 Mn |
| Dec 31, 2021 | 43.02 Mn |
| Sep 30, 2021 | 33.31 Mn |
Achieve Life Sciences Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ACHV&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "ACHV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ACHV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();